Pancreatic Cancer Screening for At-risk Individuals | MicrobiomeTrials← Back to trialsNCT05006131
Pancreatic Cancer Screening for At-risk Individuals
RecruitingOBSERVATIONAL
Trial Details
Start: 2020-07-10Est. Completion: 2032-12-31
Enrollment target: 1,395 participants Locations- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Pancreatic CancerColo-rectal CancerGastric CancerEsophageal CancerBladder CancerOvarian CancerAbdominal Surgery Complications
The goal of this clinical study is to learn whether a prehabilitation program can improve recovery after major abdominal…
Multiple LocationsEst. completion Dec 15, 2029
CancerPDAC - Pancreatic Ductal AdenocarcinomaNSCLC (Non-small Cell Lung Cancer)
CRC (Colorectal Cancer)
Advanced Solid Tumors
The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumor…
Orlando, United StatesEst. completion May 2029
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Claudin 18.2 protein, or CLDN18.2 is a protein found on cells in the digestive system. It is also found on some tumors. …
Orange, United StatesEst. completion May 31, 2028